AKT1 and glioma: Moreover, intragastric administration of PHOR in a dose of 1.5 g/kg BW to a nude mouse model of glioma remarkably slowed glioma growth and increased the levels of TNF-α, IL-1β, and IL-6 through the activation of PI3K/AKT signaling [127].